A STUDY ON THE LEVEL OF DRUG COMPLIANCE AMONG THE OUTPATIENTS WHO ARE ON A LONG-TERM DRUG THERAPY IN A TERTIARY CARE TEACHING HOSPITAL AT KANCHEEPURAM DISTRICT IN TAMILNADU
Objectives: To evaluate the drug compliance level among the patients attending the outpatient department of Shri Sathya Sai Medical College Hospital
using Morisky 8-item drug compliance questionnaire and to determine the factors which hinder them from adhering to physicianâ€™s prescription.
Methods: 100 patients who were on long-term drug treatment on outpatient basis were selected. Following that, Morisky 8-item drug compliance
questionnaire, a self-reported scale of medication adherence was used. Along with the mentioned questions, a few questions to assess factors causing
noncompliancy and their knowledge on drug compliance were included. Data were collected and based on the scale, the level of compliance, i.e., low,
medium or high was estimated. Patients found noncompliant, factors hindering them from being noncompliant were assessed.
Results: Among the 100 patients, 33% belonged to low adherence group, 44% to medium adherence group, and 23% to high adherence group.
Patients belonging to low and medium adherence group were segregated and their individual questionnaire was assessed and reason for being
noncompliant analyzed. The majority of the low adherence group said that they discontinue treatment once they feel that their symptoms were under
Conclusion: Drug noncompliance is an important factor for treatment failure. The importance of medication adherence was re-emphasized to those
patients who belonged to low/medium adherence group.
Keywords: Morisky, Drug compliance, Shri Sathya Sai, Low adherence.
1. Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet 1994;27(3):202-15.
2. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288(4): 462-7.
3. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J; VA Naltrexone Study Group. Medication compliance feedback and monitoring in a
Asian J Pharm Clin Res, Vol 10, Issue 3, 2017, 174-176
Lavakumar and Jesurun
AQ1: Kindly mention corresponding author and also provide email id
clinical trial: Predictors and outcomes. Value Health 2003;6(5):566-73.
4. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: Clinical applications. JAMA 2002;288(22):2880-3.
5. Salzman C. Medication compliance in the elderly. J Clin Psychiatry 1995;56 Suppl 1:18-22.
6. Haynes RB. A critical review of the determinants of patient compliance with therapeutic regimens. In: Sackett DL, Haynes RB, editors. Compliance with Therapeutic Regimens. Baltimore: The Johns Hopkins University Press; 1976.
7. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals. Circulation 1997;95(4):1085-90.
8. Cramer J. Identifying and improving compliance patterns. Cramer JA, Spilker B, editors. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991. p. 387-92.
9. Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002;17(10):756-65.
10. Elliott WJ, Maddy R, Toto R, Bakris G. Hypertension in patients with diabetes. Overcoming barriers to effective control. Postgrad Med 2000;107(3):29-32, 35-6, 38.
11. Black HR. Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited. Am J Hypertens 1999;12:225S-30.
12. Ickovics JR, Meade CS. Adherence to HAART among patients with HIV: Breakthroughs and barriers. AIDS Care 2002;14(3):309-18.
13. Venkateswararao S, Stephen AS, Indoria K, Rama P. Evaluation and pharmacistâ€™s intervention for improving adherence among renal failure patients. Int J Pharm Pharm Sci 2015;7(3):82-5.
14. Wee AS, Bin MS, Said M, Adyani BM. Medication adherence status among rheumatoid arthritis patients. Int J Pharm Pharm Sci 2016;8(7);317-21.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.